| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |